Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434–48.

Article  CAS  PubMed  Google Scholar 

Wang Z, Zhang Y, Xu C, Peng A, Qin H, Yao K. Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology. Biochem Pharmacol. 2025;236:116902.

Article  CAS  PubMed  Google Scholar 

Green KR, Beazley-Long N, Lynch AP, Allen CL, Bates DO, Benest AV. Quantification of angiogenesis in laser choroidal neovascularization. Methods Mol Biol. 2022;2441:223–31.

Article  CAS  PubMed  Google Scholar 

Yang F, Hu R. Efficacy and safety of intravitreal conbercept and triamcinolone acetonide for wet age-related macular degeneration in China: a meta-analysis. Int Ophthalmol. 2024;44:424.

Article  PubMed  PubMed Central  Google Scholar 

Kumar A, Ferro Desideri L, Ting MYL, Anguita R. Perspectives on the currently available pharmacotherapy for wet macular degeneration. Expert Opin Pharmacother. 2024;25:755–67.

Article  CAS  PubMed  Google Scholar 

Mulligan K, Seabury SA, Dugel PU, Blim JF, Goldman DP, Humayun MS. Economic value of anti-vascular endothelial growth factor treatment for patients with wet age-related macular degeneration in the united states. JAMA Ophthalmol. 2020;138:40–7.

Article  PubMed  Google Scholar 

Liu C, Su W, Jiang X, Lv Y, Kong F, Chen Q, et al. A sustainable retinal drug co-delivery for boosting therapeutic efficacy in wAMD: unveiling multifaceted evidence and synergistic mechanisms. Adv Healthc Mater. 2024;13:e2303659.

Article  PubMed  Google Scholar 

Huang C, Wang Y, Huang J, Liu H, Chen Z, Jiang Y, et al. A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration. Bioeng Transl Med. 2024;9:e10632.

Article  CAS  PubMed  Google Scholar 

Su W, Liu C, Jiang X, Lv Y, Chen Q, Shi J, et al. An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD. J Nanobiotechnology. 2023;21:71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo Y, Li C. Advances in research related to microrna for diabetic retinopathy. J Diabetes Res. 2024;2024:8520489.

Article  PubMed  PubMed Central  Google Scholar 

Dhillon N, Santiago C. Management of acute proliferative diabetic retinopathy related complications during the first COVID-19 wave. BMC Ophthalmol. 2022;22:119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Hou H, Li J, Zhang K. Angiopoietins/Tie2 signaling axis and its role in angiogenesis of psoriasis. Acta Histochem. 2025;127: 152228.

Article  CAS  PubMed  Google Scholar 

Chen-Li G, Martinez-Archer R, Coghi A, Roca JA, Rodriguez FJ, Acaba-Berrocal L, et al. Beyond VEGF: angiopoietin-tie signaling pathway in diabetic retinopathy. J Clin Med. 2024;13:2778.

Wallace RG, Rochfort KD, Barabas P, Curtis TM, Uehara H, Ambati BK, et al. COMP-Ang1: Therapeutic potential of an engineered Angiopoietin-1 variant. Vascul Pharmacol. 2021;141: 106919.

Article  CAS  PubMed  Google Scholar 

Khan M, Aziz AA, Shafi NA, Abbas T, Khanani AM. Targeting angiopoietin in retinal vascular diseases: a literature review and summary of clinical trials involving faricimab. Cells. 2020.

Zhang Y, Lin S, Liu J, Chen Q, Kang J, Zhong J, et al. Ang1/Tie2/VE-cadherin signaling regulates DPSCs in vascular maturation. J Dent Res. 2024;103:101–10.

Article  CAS  PubMed  Google Scholar 

Zhang ZS, Yang A, Luo X, Zhou HN, Liu YY, Bao DQ, et al. Pericyte-derived extracellular vesicles improve vascular barrier function in sepsis via the Angpt1/PI3K/AKT pathway and pericyte recruitment: an in vivo and in vitro study. Stem Cell Res Ther. 2025;16:70.

Article  PubMed  PubMed Central  Google Scholar 

Li W, Wei D, Xie X, Liang J, Song K, Huang L. Dl-3-n-Butylphthalide regulates the Ang-1/Ang-2/Tie-2 signaling axis to promote neovascularization in chronic cerebral hypoperfusion. Biomed Pharmacother. 2019;113:108757.

Article  PubMed  Google Scholar 

Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov. 2017;16:635–61.

Article  CAS  PubMed  Google Scholar 

Patel S, Yang E, Milne TJ, Hussaini H, Cooper PR, Friedlander LT. Angiogenic effects of Type 2 diabetes on the dental pulp. Int Endod J. 2025;58:434–48.

Article  CAS  PubMed  Google Scholar 

Shah AV, Birdsey GM, Peghaire C, Pitulescu ME, Dufton NP, Yang Y, et al. The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability. Nat Commun. 2017;8:16002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saini S, Tuli HS, Saini RV, Saini AK, Sak K, Kaur D, et al. Flavonoid-mediated suppression of tumor angiogenesis: roles of Ang-Tie/PI3K/AKT. Pathophysiology. 2024;31:596–607.

Article  PubMed  PubMed Central  Google Scholar 

Tang F, Huang K, Peng B, Deng W, Su N, Xu F, et al. RhoA/ROCK signaling is involved in pathological retinal neovascularization. J Vasc Res. 2023;60:183–92.

Article  PubMed  Google Scholar 

Tetik-Elsherbiny N, Elsherbiny A, Setya A, Gahn J, Tang Y, Gupta P, et al. RNF20-mediated transcriptional pausing and VEGFA splicing orchestrate vessel growth. Nat Cardiovasc Res. 2024;3:1199–216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miyamura Y, Kamei S, Matsuo M, Yamazaki M, Usuki S, Yasunaga K, et al. FOXO1 stimulates tip cell-enriched gene expression in endothelial cells. iScience. 2024;27:109161.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem. 2007;282:23910–8.

Article  CAS  PubMed  Google Scholar 

Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-Kinase/Akt signal transduction pathway. Circ Res. 2000;86:24–9.

Article  CAS  PubMed  Google Scholar 

Richter RP, Ashtekar AR, Zheng L, Pretorius D, Kaushlendra T, Sanderson RD, et al. Glycocalyx heparan sulfate cleavage promotes endothelial cell angiopoietin-2 expression by impairing shear stress-related AMPK/FoxO1 signaling. JCI Insight. 2022;7:e155010.

Dharaneeswaran H, Abid MR, Yuan L, Dupuis D, Beeler D, Spokes KC, et al. FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis. Circ Res. 2014;115(2):238–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang L, Shan Y, Ji X, Zhu M, Li C, Sun Y, et al. Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents. Oncotarget. 2017;8:104745–60.

Article  PubMed  PubMed Central  Google Scholar 

Mammoto T, Mammoto A, Ingber DE. Mechanobiology and developmental control. Annu Rev Cell Dev Biol. 2013;29:27–61.

Article  CAS  PubMed  Google Scholar 

Daly C, Wong V, Burova E, Wei Y, Zabski S, Griffiths J, et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 2004;18(9):1060–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campochiaro PA, Peters KG. Targeting Tie2 for treatment of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2016;16:126.